Company news
Hemostemix Inc news in 2020
Hemostemix Inc's news releases, calls and decks from 2020, newest first.
Hemostemix Announces Private Placement Update
December 29, 2020
Hemostemix Announces Corporate Update
December 23, 2020
Hemostemix Announces Closing of Existing Private Placement and Announces a New Private Placement
December 18, 2020
InvestmentPitch Media Video Discusses Hemostemix Successfully Obtaining all Clinical Trial Data and Announcement of $2.5 Million Unit Offering - Video Available on Investmentpitch.com
December 1, 2020
Hemostemix Files Its Unaudited Condensed Consolidated Interim Financial Statements and Management Discussion and Analysis for the Three Months Ended March 31, 2020
July 13, 2020
Hemostemix Files Its Audited Annual Financial Statements and Management Discussion and Analysis for the Period Ending December 31, 2019
July 10, 2020
Hemostemix Announces Closing of Private Placement
July 9, 2020
Delaware Court Grants An Order for the Expedited Briefing Schedule of Hemostemix's Injunction against Accudata Solutions, Inc. and Hemostemix is in Receipt of an Unsigned Report from Aspire Health Science
July 6, 2020
Hemostemix Filed an Injunction Against Accudata Solutions, Inc. for the Return of its Clinical Trial Midpoint Report and Data
July 3, 2020
Hemostemix Appeals Alberta Court's Service Ex Juris Decision
June 24, 2020
Hemostemix Announces $700,000 Non Broker Private Placement, Update on its Proceedings against Aspire Health Science, LLC
June 19, 2020
Hemostemix Announces Delay in Filing of Annual Financial Statements and Application for Management Cease Trade Order
June 16, 2020
Hemostemix Announces Aspire Health Science, LLC Has No Right to Manufacture or to Sublicense Hemostemix's Intellectual Property
June 8, 2020
Hemostemix Announces Dr. Mary Argent-Katwala as Its Clinical Trial Manager
June 3, 2020
Hemostemix Announces Injunction Hearing Against Aspire Health Science, LLC
June 3, 2020
Hemostemix Announces Annual Special Meeting Results
May 7, 2020
Hemostemix Announces the Appointment of David Tsubouchi to its Board of Advisors
April 30, 2020
Hemostemix Announces Private Placement and Debt Settlement Update
April 29, 2020
Hemostemix Announces the Appointment of Timothy Chang to Board of Advisors
April 21, 2020
Hemostemix Announces the Appointments of Loran Swanberg and Christina Wu, CPA, CGA
April 9, 2020
Hemostemix Appoints the Honourable Sheila Copps, OC, PC, to Board of Advisors and Ratifies Thomas Smeenk as Chief Executive Officer
April 7, 2020
Hemostemix Announces Closing of Second Tranche of Private Placement
March 26, 2020
Hemostemix Announces Peter Lacey as Chairman of the Board of Directors
March 19, 2020
Hemostemix Announces Dr. York Hsiang Joins Its Scientific Advisory Board
March 16, 2020
Hemostemix Announces Closing of First Tranche of Private Placement
March 5, 2020